Items tagged with Access

Activism delivers unprecedented victories in TB testing and treatment access (post with simple image)

Historic price reductions will allow millions more people to receive TB prevention, treatment and testing.

An Activist’s Guide to Shorter Treatment for Drug-Resistant TB (post with simple image)

This new resource lays out what activists need to know about the new drug-resistant TB treatment regimens, and equips them with actions they can take and arguments they can use to advocate for access to those regimens.

Technical brief: Access to TB testing and treatments: GeneXpert and delamanid (post with simple image)

Médecins Sans Frontières issues a report offering case studies of two critical TB tools, GeneXpert and delamanid, and outlining actions that the corporations making them need to take to unlock access to these tools.

Addressing the needs of people with extensively drug-resistant TB through pre-approval access to drugs and research (post with simple image)

A viewpoint, published in Public Health Action, advocates for transparent, accessible pre-approval access as a core element of person-centered care for drug-resistant TB.

Stop TB Partnership announces the Legal Environment and Human Rights Scorecard (post with simple image)

The Scorecard aims to enhance visibility and multisectoral accountability regarding legal, policy and human rights barriers experienced by people affected by TB.

Call to Action: Shorter and more effective treatment for all people suffering from drug-resistant TB (post with simple image)

Sign up for a Call to Action for accelerating the implementation of shorter and more effective treatment for all people with drug-resistant TB.

Lindsay McKenna: What does it mean to be a good activist? (post with simple image)

At the 2023 Union Conference, TAG's Lindsay McKenna sat down with Denis Godlevsky of ITPC EECA for a wide-ranging discussion on TB research, activism, and TAG's historic + present role shaping both.

The rejection of the bedaquiline patent opposition in Indonesia raises the risk of difficulty in accessing optimal TB therapy (post with simple image)

The patent opposition was submitted by the Indonesia AIDS Coalition and Indonesia for Global Justice in November 2022 and was rejected by a decision from the Judiciary Panel on 9 November 2023.

What will it take to end TB? (post with simple image)

A story tells how the endTB project has improved TB care through a series of scientific studies while pushing the boundaries of what’s thought possible: in clinical trials, in epidemiology, and in the thinking about where you can do the science required to deliver world-class health care where it’s needed most.

Page 80 of 80 · Total posts: 0

←First 79 80